Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three-Arm Randomised Controlled Trial Comparing Either Continuous Chemotherapy Plus Cetuximab or Intermittent Chemotherapy With Standard Continuous Palliative Combination Chemotherapy With Oxaliplatin and a Fluoropyrimidine in First Line Treatment of Metastatic Colorectal Cancer (COIN)

NCT00182715 is registered in ClinicalTrials.gov with Velindre NHS Trust as lead sponsor.

NCT NCT00182715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three-Arm Randomised Controlled Trial Comparing Either Continuous Chemotherapy Plus Cetuximab or Intermittent Chemotherapy With Standard Continuous Palliative Combination Chemotherapy With Oxaliplatin and a Fluoropyrimidine in First Line Treatment of Metastatic Colorectal Cancer (COIN)
Lead sponsor
Velindre NHS Trust
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2005
Completion date
Not reported
Enrollment
2,421 (estimated)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer